Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Leukemia

Free Subscription Articles published in Exp Cell Res Retrieve available abstracts of 25 articles: HTML format

Single Articles

June 2021
1. LIU Z, Zheng W, Liu Y, Zhou B, et al
   Targeting HSPA8 inhibits proliferation via downregulating BCR-ABL and enhances chemosensitivity in imatinib-resistant chronic myeloid leukemia cells.
   Exp Cell Res. 2021 Jun 19:112708. doi: 10.1016/j.yexcr.2021.112708.
   PubMed     Abstract available
   
   
   March 2021
2. YU W, Lutz C, Kramer A, Schmidt-Zachmann MS, et al
   The JmjC-domain protein NO66/RIOX-1 affects the balance between proliferation and maturation in acute myeloid leukemia.
   Exp Cell Res. 2021 Mar 18:112566. doi: 10.1016/j.yexcr.2021.112566.
   PubMed     Abstract available
   
   
   January 2021
3. WANG C, Li L, Li M, Shen X, et al
   Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371].
   Exp Cell Res. 2021 Jan 8:112469. doi: 10.1016/j.yexcr.2020.112469.
   PubMed    
   
   
   November 2020
4. JAMALPOUR M, Bergquist E, Welsh M
   Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
   Exp Cell Res. 2020 Nov 18:112368. doi: 10.1016/j.yexcr.2020.112368.
   PubMed     Abstract available
   
   
   
5. WANG C, Li L, Li M, Shen X, et al
   Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia.
   Exp Cell Res. 2020 Nov 11:112371. doi: 10.1016/j.yexcr.2020.112371.
   PubMed     Abstract available
   
   
   October 2020
6. ZHAO F, Sun L, Yang N, Zheng W, et al
   Increased release of microvesicles containing mitochondria is associated with the myeloid differentiation of AML-M5 leukaemia cells.
   Exp Cell Res. 2020;395:112213.
   PubMed     Abstract available
   
   
   May 2020
7. CHEN C, Wang L, Li L, Wang A, et al
   Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia.
   Exp Cell Res. 2020 May 3:112054. doi: 10.1016/j.yexcr.2020.112054.
   PubMed     Abstract available
   
   
   April 2020
8. RASHID A, Wang R, Zhang L, Yue J, et al
   Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
   Exp Cell Res. 2020 Apr 10:111989. doi: 10.1016/j.yexcr.2020.111989.
   PubMed     Abstract available
   
   
   
9. LI D, Yu Z, Wang T, Li Y, et al
   The role of the novel LincRNA uc002jit.1 in NF-kB-mediated DNA damage repair in acute myeloid leukemia cells.
   Exp Cell Res. 2020 Apr 4:111985. doi: 10.1016/j.yexcr.2020.111985.
   PubMed     Abstract available
   
   
   February 2020
10. DENG M, Zha J, Zhao H, Jia X, et al
    Apatinib exhibits cytotoxicity toward leukemia cells by targeting VEGFR2-mediated prosurvival signaling and angiogenesis.
    Exp Cell Res. 2020 Feb 29:111934. doi: 10.1016/j.yexcr.2020.111934.
    PubMed     Abstract available
    
    
    
11. SHI K, An J, Qian K, Zhao X, et al
    p53 controls the switch between autophagy and apoptosis through regulation of PLSCR1 in sodium selenite-treated leukemia cells.
    Exp Cell Res. 2020 Feb 1:111879. doi: 10.1016/j.yexcr.2020.111879.
    PubMed     Abstract available
    
    
    September 2019
12. YU Q, Xu Y, Zhuang H, Wu Z, et al
    Aberrant activation of RPB1 is critical for cell overgrowth in acute myeloid leukemia.
    Exp Cell Res. 2019 Sep 28:111653. doi: 10.1016/j.yexcr.2019.111653.
    PubMed     Abstract available
    
    
    May 2019
13. WANG MM, Zhuang LK, Zhang YT, Xia D, et al
    A novel specific cleavage of IkappaBalpha protein in acute myeloid leukemia cells involves protease PR3.
    Exp Cell Res. 2019 May 21. pii: S0014-4827(19)30263.
    PubMed     Abstract available
    
    
    
14. MORAD SAF, MacDougall MR, Abdelmageed N, Kao LP, et al
    Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.
    Exp Cell Res. 2019 May 18. pii: S0014-4827(19)30262.
    PubMed     Abstract available
    
    
    February 2019
15. CHEN P, Zhan W, Wang B, You P, et al
    Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells.
    Exp Cell Res. 2019 Feb 11. pii: S0014-4827(19)30056.
    PubMed     Abstract available
    
    
    November 2018
16. LANG W, Zhu J, Chen F, Cai J, et al
    EVI-1 Modulates Arsenic Trioxide induced Apoptosis through JNK signaling pathway in Leukemia Cells.
    Exp Cell Res. 2018 Nov 22. pii: S0014-4827(18)30852.
    PubMed     Abstract available
    
    
    
17. ZHAO H, Li Z, Xie S, Luo Y, et al
    Impairment of Valpha24-Jalpha18(+)Vbeta11(+) natural killer T cells in adult acute lymphoblastic leukemia patients.
    Exp Cell Res. 2018 Nov 12. pii: S0014-4827(18)30855.
    PubMed     Abstract available
    
    
    September 2018
18. LU X, Zhuang H, Yu Q, Zhang X, et al
    Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia.
    Exp Cell Res. 2018 Sep 1. pii: S0014-4827(18)30541.
    PubMed     Abstract available
    
    
    July 2018
19. BAMODU OA, Kuo KT, Yuan LP, Cheng WH, et al
    HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1.
    Exp Cell Res. 2018 Jul 12. pii: S0014-4827(18)30440.
    PubMed     Abstract available
    
    
    May 2018
20. WENJIAN G, Jingrui J, Jiajia P, Rongxing Y, et al
    The change of nuclear LC3 distribution in acute myeloid leukemia cells.
    Exp Cell Res. 2018 May 9. pii: S0014-4827(18)30269.
    PubMed     Abstract available
    
    
    
21. HE L, Shi L, Du Z, Huang H, et al
    Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia.
    Exp Cell Res. 2018 May 8. pii: S0014-4827(18)30268.
    PubMed     Abstract available
    
    
    February 2018
22. TIAN WL, Guo R, Wang F, Jiang ZX, et al
    The IRF9-SIRT1-P53 Axis is Involved in the Growth of Human Acute Myeloid Leukemia.
    Exp Cell Res. 2018 Feb 28. pii: S0014-4827(18)30120.
    PubMed     Abstract available
    
    
    December 2017
23. MIN QH, Wang XZ, Zhang J, Chen QG, et al
    Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365.
    Exp Cell Res. 2017 Dec 6. pii: S0014-4827(17)30643.
    PubMed     Abstract available
    
    
    April 2017
24. WANG X, Li Y, Chen W, Wang Y, et al
    Nrf-2/Gst-alpha mediated imatinib resistance through rapid 4-HNE clearance.
    Exp Cell Res. 2017;353:72-78.
    PubMed     Abstract available
    
    
    February 2017
25. SHI XF, Wang H, Kong FX, Xu QQ, et al
    Exosomal miR-486 regulates hypoxia-induced erythroid differentiation of erythroleukemia cells through targeting Sirt1.
    Exp Cell Res. 2017;351:74-81.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: